TotalMarketCap

DataMeds AI

MEDSNasdaq United StatesHealth CareOther Pharmaceuticals

Market cap

$5.830 M

$1.21 -18.79%

Close of 6 Nov 2026

As of 6 Nov 2026, DataMeds AI (MEDS) has a market capitalization of $5.83M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$23.3M

#2927 by revenue

Earnings

-$101.3M

Loss-making

Shares outstanding

3,061,919

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other Pharmaceuticals, ranked by market cap

All 10 →
  1. #6ZeroStackZSTK$56.7M
  2. #7EnerSyn GlobalESYN$46.4M
  3. #8Cosmos HealthCOSM$29.2M
  4. #9DataMeds AIMEDS$5.83M
  5. #10Cellyan BiotechnologyHKPD$3.35M

What if DataMeds AI were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,860,182

Per share 4,843,125× higher

Bitcoin $1.53T

$317,084.23

Per share 262,053× higher

Apple $5.02T

$1,040,958

Per share 860,296× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for DataMeds AI are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.